Zhejiang Huakang Pharmaceutical Co (SHSE:605077) Accounts Payable & Accrued Expense : ¥529 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Zhejiang Huakang Pharmaceutical Co Accounts Payable & Accrued Expense?

Zhejiang Huakang Pharmaceutical Co's quarterly accounts payable & accrued expense increased from Sep. 2023 (¥469 Mil) to Dec. 2023 (¥558 Mil) but then declined from Dec. 2023 (¥558 Mil) to Mar. 2024 (¥529 Mil).

Zhejiang Huakang Pharmaceutical Co's annual accounts payable & accrued expense increased from Dec. 2021 (¥326 Mil) to Dec. 2022 (¥413 Mil) and increased from Dec. 2022 (¥413 Mil) to Dec. 2023 (¥558 Mil).

Zhejiang Huakang Pharmaceutical Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Zhejiang Huakang Pharmaceutical Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Huakang Pharmaceutical Co Accounts Payable & Accrued Expense Chart

Zhejiang Huakang Pharmaceutical Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

252.95

256.86

326.18

412.68

558.27

Zhejiang Huakang Pharmaceutical Co Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															455.86	502.26	468.89	558.27	529.12

Zhejiang Huakang Pharmaceutical Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Zhejiang Huakang Pharmaceutical Co (SHSE:605077) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Zhejiang Huakang Pharmaceutical Co Ltd (SHSE:605077) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

No. 18, Huagong Road, Huabu Town, Zhejiang Province, Kaihua County, Quzhou, CHN, 324302

Website

http://www.huakangpharma.com

Zhejiang Huakang Pharmaceutical Co Ltd is engaged in the research and development, production and sales of various functional sugar alcohols and starch sugar products such as xylitol, sorbitol, maltitol, fructose syrup and others.

Executives

Du Yong Rui	Director
Zheng Fang Ming	senior management
Jiang Xue Song	Supervisors
Yu Jian Ming	Directors, senior managers
Chen De Shui	Directors, senior managers
Xu Xiao Rong	Director
Cheng Xin Ping	Directors, senior managers
Yan Xiao Xing	Supervisors
Cao Jian Hong	Director

Zhejiang Huakang Pharmaceutical Co (SHSE:605077) Headlines

No Headlines